AMICUS THERAPEUTICS INC (FOLD)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for FOLD
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| FOLD | President and Chief Executive Officer | 49 | ["Over 20 years of experience in the Orphan Drug industry", "Led the global organization responsible for the commercialization of Galafold\u00ae", "Oversaw Technical Operations, Market Access, Program Management, Clinical Operations, and Regulatory Affairs functions", "Served on the Boards of Gennao Bio and ARYA Sciences Acquisition Corp III", "Experience at Progenics Pharmaceuticals", "Various commercial and business development roles at Genzyme and Bristol-Myers Squibb", "Strategy consultant for Marakon Associates", "B.A. in Public Policy Studies from Duke University", "M.B.A. from Harvard Business School"] | ["Corporate Advisory Board for the National Tay-Sachs and Allied Diseases Association", "Board of the Biotechnology Innovation Organization", "Duke-Margolis Advisory Board"] | 2025 |